ReviewCell communication and signaling : CCS2026
Small but mighty: mitochondrial DNA at the centre of retrograde signalling.
Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Mitochondria form highly dynamic and interconnected networks that continuously communicate with the cytoplasm and the nucleus to maintain cellular homeostasis and coordinate adaptive responses to stress. This bidirectional communication, known as mito-nuclear crosstalk, is essential for regulating metabolism, redox balance, immune activation, and cell fate decisions. While retrograde signalling has traditionally been viewed as a consequence of metabolic or oxidative perturbations, mounting evidence positions mitochondrial DNA (mtDNA) as a central and active regulator of these signalling pathways. Beyond encoding essential subunits of the electron transport chain, mtDNA functions as a signalling hub that conveys information about mitochondrial functional status to the nucleus. Perturbations in mtDNA integrity, copy number, or expression initiate retrograde responses through metabolic rewiring, alterations in redox and calcium signalling, and activation of stress-responsive transcriptional programmes. In addition, mtDNA-derived products, including mitochondrial-derived non-coding RNAs (mt-ncRNAs) and mitochondrial-derived peptides (MDPs), have emerged as key messengers that shuttle between cellular compartments, reshape nuclear gene expression, and influence cellular and systemic responses to stress. These molecules participate in diverse processes, ranging from mitochondrial biogenesis and quality control to innate immune activation and epigenetic regulation. This review synthesises current knowledge on mtDNA-driven retrograde signalling, highlighting both classical and emerging mechanisms by which the mitochondrial genome communicates with the nucleus. We discuss how mtDNA instability, defective repair, and altered mitochondrial dynamics trigger signalling cascades involving metabolic sensors, calcium fluxes, and innate immune pathways. We further examine the growing evidence supporting regulatory roles for mt-ncRNAs, including small RNAs, long non-coding RNAs, double-stranded RNAs, and circular RNAs, as well as MDPs such as Humanin, SHLPs, and MOTS-c, in coordinating adaptive nuclear responses.By integrating these diverse signalling modalities, this review highlights mtDNA as an integral and active signalling platform that coordinates mitochondrial stress sensing with nuclear adaptive responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.